NICOX SA (ALCOX.PA) Fundamental Analysis & Valuation

EPA:ALCOXFR0013018124

Current stock price

0.41 EUR
+0 (+0.49%)
Last:

This ALCOX.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ALCOX.PA Profitability Analysis

1.1 Basic Checks

  • ALCOX had negative earnings in the past year.
  • In the past 5 years ALCOX always reported negative net income.
  • ALCOX had a negative operating cash flow in each of the past 5 years.
ALCOX.PA Yearly Net Income VS EBIT VS OCF VS FCFALCOX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

  • The Return On Assets of ALCOX (-179.67%) is worse than 87.34% of its industry peers.
Industry RankSector Rank
ROA -179.67%
ROE N/A
ROIC N/A
ROA(3y)-53.69%
ROA(5y)-42.4%
ROE(3y)-266.03%
ROE(5y)-174.79%
ROIC(3y)N/A
ROIC(5y)N/A
ALCOX.PA Yearly ROA, ROE, ROICALCOX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600

1.3 Margins

  • ALCOX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALCOX.PA Yearly Profit, Operating, Gross MarginsALCOX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K -80K -100K

3

2. ALCOX.PA Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, ALCOX has more shares outstanding
  • Compared to 5 years ago, ALCOX has more shares outstanding
  • ALCOX has a worse debt/assets ratio than last year.
ALCOX.PA Yearly Shares OutstandingALCOX.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ALCOX.PA Yearly Total Debt VS Total AssetsALCOX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of -57.26, we must say that ALCOX is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -57.26, ALCOX is doing worse than 91.14% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -57.26
ROIC/WACCN/A
WACCN/A
ALCOX.PA Yearly LT Debt VS Equity VS FCFALCOX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • ALCOX has a Current Ratio of 11.02. This indicates that ALCOX is financially healthy and has no problem in meeting its short term obligations.
  • ALCOX has a Current ratio of 11.02. This is amongst the best in the industry. ALCOX outperforms 93.67% of its industry peers.
  • A Quick Ratio of 11.02 indicates that ALCOX has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 11.02, ALCOX belongs to the top of the industry, outperforming 93.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 11.02
Quick Ratio 11.02
ALCOX.PA Yearly Current Assets VS Current LiabilitesALCOX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

6

3. ALCOX.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 23.81% over the past year.
  • Looking at the last year, ALCOX shows a quite strong growth in Revenue. The Revenue has grown by 13.86% in the last year.
  • ALCOX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.77% yearly.
EPS 1Y (TTM)23.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-71.43%
Revenue 1Y (TTM)13.86%
Revenue growth 3Y2.81%
Revenue growth 5Y2.77%
Sales Q2Q%-74.79%

3.2 Future

  • The Earnings Per Share is expected to grow by 58.75% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, ALCOX will show a very strong growth in Revenue. The Revenue will grow by 102.03% on average per year.
EPS Next Y96%
EPS Next 2Y58.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year230%
Revenue Next 2Y102.03%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALCOX.PA Yearly Revenue VS EstimatesALCOX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M
ALCOX.PA Yearly EPS VS EstimatesALCOX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.2 -0.4 -0.6 -0.8 -1

4

4. ALCOX.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALCOX. In the last year negative earnings were reported.
  • With a Price/Forward Earnings ratio of 3.06, the valuation of ALCOX can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, ALCOX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of ALCOX to the average of the S&P500 Index (22.67), we can say ALCOX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 3.06
ALCOX.PA Price Earnings VS Forward Price EarningsALCOX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALCOX.PA Per share dataALCOX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2 -0.3

4.3 Compensation for Growth

  • ALCOX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ALCOX's earnings are expected to grow with 58.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y58.75%
EPS Next 3YN/A

0

5. ALCOX.PA Dividend Analysis

5.1 Amount

  • ALCOX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ALCOX.PA Fundamentals: All Metrics, Ratios and Statistics

NICOX SA

EPA:ALCOX (3/23/2026, 7:00:00 PM)

0.41

+0 (+0.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-15
Earnings (Next)04-28
Inst Owners4.12%
Inst Owner ChangeN/A
Ins Owners0.33%
Ins Owner ChangeN/A
Market Cap36.26M
Revenue(TTM)3.32M
Net Income(TTM)-26.95M
Analysts84.44
Price Target1.53 (273.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3.06
P/S 10.92
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.36
EYN/A
EPS(NY)0.13
Fwd EY32.66%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.04
BVpS-0.05
TBVpS-0.05
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -179.67%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-53.69%
ROA(5y)-42.4%
ROE(3y)-266.03%
ROE(5y)-174.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.02
Quick Ratio 11.02
Altman-Z -57.26
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-71.43%
EPS Next Y96%
EPS Next 2Y58.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.86%
Revenue growth 3Y2.81%
Revenue growth 5Y2.77%
Sales Q2Q%-74.79%
Revenue Next Year230%
Revenue Next 2Y102.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-101.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year67.32%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

NICOX SA / ALCOX.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of NICOX SA (ALCOX.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALCOX.PA.


What is the valuation status of NICOX SA (ALCOX.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to NICOX SA (ALCOX.PA). This can be considered as Fairly Valued.


How profitable is NICOX SA (ALCOX.PA) stock?

NICOX SA (ALCOX.PA) has a profitability rating of 0 / 10.


Can you provide the financial health for ALCOX stock?

The financial health rating of NICOX SA (ALCOX.PA) is 3 / 10.